PB1850: A DOSE FINDING AND EXPANSION OPEN LABEL, MULTICENTER STUDY OF IADADEMSTAT AND GILTERITINIB IN PATIENTS WITH RELAPSE/REFRACTORY ACUTE MYELOID LEUKEMIA WITH MUTATED FLT3: THE FRIDA STUDY

• A. Fathi,
• A. Molero,
• S. Gutierrez,
• M. Arévalo,
• H. Yang,
• C. Buesa,
• A. Limon

Affiliations

A. Fathi

1 Leukemia Department, Massachusetts General Hospital, Boston, United States of America

A. Molero

2 Oryzon Genomics SA, Cornella de Llobregat, Spain

S. Gutierrez

2 Oryzon Genomics SA, Cornella de Llobregat, Spain

M. Arévalo

2 Oryzon Genomics SA, Cornella de Llobregat, Spain

H. Yang

2 Oryzon Genomics SA, Cornella de Llobregat, Spain

C. Buesa

2 Oryzon Genomics SA, Cornella de Llobregat, Spain

A. Limon

2 Oryzon Genomics SA, Cornella de Llobregat, Spain